Long‐Term Dynamic Changes of Alanine Aminotransferase Levels Are Associated With Liver‐Related Events in Nucleos(t)ide Analogue‐Treated Chronic Hepatitis B Patients in China
Alimentary Pharmacology & Therapeutics · 2025
DOI: 10.1111/apt.70195 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2025. Verfasst von Rong Fan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Nanfang Hospital, Southern Medical University; State Key Laboratory of Organ Failure Research; Key Laboratory of I…. Hauptthemen laut MEDLINE: Alanine Transaminase, Antiviral Agents, Hepatitis B, Chronic, Nucleosides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Background
The role of alanine aminotransferase (ALT) dynamics during nucleos(t)ide analogue (NA) therapy in chronic hepatitis B (CHB) is unclear. We aimed to evaluate the correlation between ALT dynamics and liver‐related events (LRE), and explore the optimal threshold of ALT during NA treatment.
Methods
We enrolled 18,129 NA‐treated patients, comprising 3104 patients from the Search‐B study (NCT02167503) and 15,025 patients from a real‐world cohort in Hong Kong. Latent‐class mixed model (LCMM) was adopted to identify trajectory patterns of ALT during treatment. ALT value at the 95 th percentile of the trajectory group with the lowest LRE risk was obtained as the optimal threshold.
Results
During a median follow‐up of 53.3 months, 1164 patients developed LRE with a 7‐year cumulative incidence of 9.9%. In the Search‐B cohort, LCMM recognised 3 trajectory groups with progressively increasing ALT levels, which were positively associated with LRE risk. Subsequently, the optimal thresholds for ALT were obtained as 23 U/L for men and 16 U/L for women. The 7‐year cumulative incidence of LRE was 5.5% for ALT ≤ 23 or 16 U/L, significantly lower than that for ALT > 23 or 16 U/L but ≤ 40 U/L (10.8%; aHR = 2.0, p < 0.001), and ALT > 40 U/L (15.1%; aHR = 3.4, p < 0.001). Similarly, in the Hong Kong cohort, ALT > 23 or 16 U/L but < 40 U/L and ALT > 40 U/L also increased the LRE risk, with aHRs of 2.0 ( p = 0.003) and 6.1 ( p < 0.001), respectively.
Conclusion
On‐treatment ALT levels were significantly correlated with the prognosis of CHB. ALT ≤ 23 U/L for men and ≤ 16 U/L for women were identified as the optimal thresholds during NA treatment, suggesting that CHB patients should strive for a lower ALT level beyond the traditional normal range.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Nanfang Hospital, Southern Medical University; State Key Laboratory of Organ Failure Research; Key Laboratory of Infectious Diseases Research in South China, Ministry of Education; Gua…
- Medical Data Analytics Centre, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, the Chinese University of Hong Kong, Hong Kong, SAR, China.
ORCID-Profile: Rong Fan, Jimmy Che-To Lai, Jie Peng, Zhihong Liu, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong, Jian Sun, Terry Cheuk-Fung Yip, Jinlin Hou
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Fan, R., Yu, N., Lai, J. C., Hui, V. W., Peng, J., Chen, Y., Liu, Z., Liang, X., Chan, H. L., Yin, J., Wong, V. W., Zhong, C., Wong, G. L., Sun, J., Yip, T. C., & Hou, J. (2025). Long‐Term Dynamic Changes of Alanine Aminotransferase Levels Are Associated With Liver‐Related Events in Nucleos(t)ide Analogue‐Treated Chronic Hepatitis B Patients in China. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70195
Vancouver
Fan R, Yu N, Lai JC, Hui VW, Peng J, Chen Y, et al. Long‐Term Dynamic Changes of Alanine Aminotransferase Levels Are Associated With Liver‐Related Events in Nucleos(t)ide Analogue‐Treated Chronic Hepatitis B Patients in China. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.70195
BibTeX
@article{Fan2025,
author = {Fan, Rong and Yu, Ning and Lai, Jimmy Che-To and Hui, Vicki Wing-Ki and Peng, Jie and Chen, Yongpeng and Liu, Zhihong and Liang, Xieer and Chan, Henry Lik-Yuen and Yin, Junhua and Wong, Vincent Wai-Sun and Zhong, Chunxiu and Wong, Grace Lai-Hung and Sun, Jian and Yip, Terry Cheuk-Fung and Hou, Jinlin},
title = {Long‐Term Dynamic Changes of Alanine Aminotransferase Levels Are Associated With Liver‐Related Events in Nucleos(t)ide Analogue‐Treated Chronic Hepatitis B Patients in China},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2025},
doi = {10.1111/apt.70195}
}
EUVIMED